Imperial College London

ProfessorKoshRay

Faculty of MedicineSchool of Public Health

Chair in Public Health (Clinical)
 
 
 
//

Contact

 

+44 (0)20 7594 0716k.ray

 
 
//

Assistant

 

Mrs Jennifer Landmann +44 (0)20 7594 9602

 
//

Location

 

320Reynolds BuildingCharing Cross Campus

//

Summary

 

Membership of Professional Bodies

  • Executive Committee, European Atherosclerosis Society, 2017 - 2020
  • Fellow, American College of Cardiology
  • Fellow, American Heart Association
  • Member, British Cardiovascular Society
  • Member, European Atherosclerosis Society
  • Fellow, European Society of Cardiology
  • Member, Independent Doctors Federation
  • Member, Royal Society of Medicine

Links with Other Academic Bodies

Industrial Connections

  • AbbVie, Events Adjudication Committee Member of the SONAR clinical trial
  • AstraZeneca, National Lead Investigator of the Savor TIMI 53 clinical trial and the Declare TIMI 58 clinical trial, National Lead Investigator and Steering Committee Member of the THEMIS Phase 3 RCT clinical trial, National Lead Investigator and Executive Committee Member of the STRENGTH clinical trial
  • Cerenis, Executive Committee Member of the CARAT clinical trial
  • Eisai, Steering Committee Member of the CAMELLIA TIMI 61 clinical trial
  • Esperion, Executive Committee Member of the CLEAR CVOT clinical trial and the HARMONY Esperion Lipid Lowering Trials clinical trial
  • European Atherosclerosis Society (EAS), PI of the EAS Familial Hypercholesterolaemia (FH) Collaboration (sponsored with MSD, Amgen, and Sanofi)
  • Kowa, Steering Committee Member of the PROMINENT clinical trial
  • Lilly, Executive Committee Member of the ACCENTUATE clinical trial and the Lilly Phase 3 Lipid lowering programme of a novel PCSK9 Mab, Chair of Statin Intolerance Study
  • Medicines Company, PI and Co-chair of the Executive Committee for the ORION 1 clinical trial
  • Pfizer, PI to a grant to establish a risk prediction tool for additional lipid lowering therapies and to the global grant for dyslipidemia to establish a global collaborative registry of Familial Hypercholesterolaemia (FH)
  • Resverlogix, Chair of International Executive Committee of the BETONMACE clinical trial
  • Sanofi, PI of the Investigator Initiated TOGETHER study
  • Sanofi Regeneron, National Lead Investigator of the Odyssey Outcomes clinical trial, Executive Committee Member of the Odyssey Diabetes 1 clinical trial and the Odyssey Diabetes 2 clinical trial

Editorial Boards

  • Archives of Medicine, Associate Editor
  • European Heart Journal, International Associate Editor
  • British Journal of Cardiology
  • Future Forum - Lipids, International Board Member
  • Circulation, Editorial Board
  • European Atherosclerosis Society
  • International Journal of Clinical Practice